Service | Source | Final Application Due Date | Funding Available | Match Required |
---|---|---|---|---|
Health Care |
Federal
HHS |
01-27-2025 | N/A | No Match Required |
The NIH announces its intention to reissue PAR-21-233 to solicit applications from researchers developing diverse biotherapeutic modalities � including but not limited to antibodies, peptides, proteins, oligonucleotides, gene therapies, cell therapies, and other emerging therapeutic modalities � for the treatment of nervous system disorders. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Fall 2024 with an expected application due date in Winter 2025. This NOFO will utilize the U44 activity code. Details of the planned NOFO are provided below.
How would you rate your overall experience on our website?
How easy is it to find the information you need?
How do you rate the look & feel of our website?
How could we improve our website?